ATP6V1G2-DDX39B readthrough (non-protein coding) (ATP6V1G2-DDX39B)

ATP6V1G2-DDX39B readthrough is a non-protein coding RNA generated by transcriptional read-through between the ATP6V1G2 and DDX39B gene loci on chromosome 6[2][5][6]. This readthrough event does not result in a functional protein. Its biological significance is unknown and not clearly established; current evidence suggests only putative roles inferred from parental gene functions (energy production and RNA metabolism), but lacks experimental characterization or association with disease or therapeutic targeting in its own right[1][2]. It is not currently considered a canonical molecule for pharmaceutical or biomarker development. Summary of significance and caveats: - Not a protein, receptor, enzyme, or a canonical therapeutic target[2][6]. - No direct functional, biomarker, or pharmacological significance at this time. - Parental genes have biological/medical roles, but the fusion or readthrough entity does not inherit these roles in a defined way. - The presence of "-readthrough (non-protein coding)" is an important indicator it is a genomic/annotation artifact or a long non-coding RNA, not a target for drug action.

Other names

ATP6V1G2-DDX39B readthrough (NMD candidate)ATP6V1G2-DDX39B

None